Refractory Large B-cell Lymphoma Clinical Trials in Tianjin, Tianjin Municipality
2 recruitingTianjin, Tianjin Municipality, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
Relapsed/Refractory Large B-Cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.12 enrolled6 locationsNCT07606937
Recruiting
Phase 2
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
Relapsed/Refractory Large B-Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China89 enrolled1 locationNCT06489808